Interleukin 35 polymorphisms are associated with decreased risk of premature coronary artery disease, metabolic parameters, and IL-35 levels: the genetics of atherosclerotic disease (GEA) study.
Posadas-Sanchez R, et al.
Mediators of Inflammation, 2017, 10-10 (2017)